International Business Machines Corp. closed 6.79% below its 52-week high of $266.45, which the company achieved on March 10th.
International Business Machines Corp. closed 7.75% short of its 52-week high of $266.45, which the company reached on March ...
We recently published a list of Dobermans of the Dow: 10 Stocks to Consider. In this article, we are going to take a look at where International Business Machines Corporation (NYSE:IBM) stands against ...
The Dow Jones Industrial Average (DJIA) continues to drop today as an escalating trade war occupies investors’ minds. The big ...
Russell Investments expects the trend toward liability-hedging fixed income to persist as funded status inches upward. We ...
In early trading on Friday, shares of Sherwin-Williams topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.7%. Year to date, Sherwin-Williams Co ...
Juniper Networks and IBM are collaborating through their artificial intelligence platforms to address the complexities of managing IT networks. The collaboration between Juniper, known for its ...
Oil futures add to the previous day's losses as the market frets about the effect that U.S. trade tariffs could have on economic growth and oil demand. An unexpected 2.3 million barrel draw in U.S ...
Planned acquisition furthers IBM's commitment to open-source innovation; helps clients access untapped, unstructured enterprise data to maximize the impact of generative AI ARMONK, N.Y., Feb. 25 ...
IBM (IBM) announced its intent to acquire DataStax, an AI and data solution provider. DataStax’s technology will enhance IBM’s watsonx portfolio of products accelerating the use of generative ...
International Business Machines(NYSE: IBM) ranks as the best Dow Jones stock of the year so far. Shares of the longtime technology leader are up nearly 20%. IBM is easily on track to beat its 34% ...
I recommend accumulating shares of Merck and Procter & Gamble in 2025, leveraging the Dogs of the Dow strategy for a combination of value and growth. Merck is undervalued with strong fundamentals ...